the staff of the Ridgewood blog
Ridgewood NJ, the U.S. Food and Drug Administration (FDA) has announced major changes to how annual COVID-19 boosters are approved in the U.S., signaling a shift in vaccination policy that could limit eligibility to older adults and high-risk individuals. The new guidance, published in the New England Journal of Medicine, emphasizes the need for new clinical trials before extending yearly COVID-19 vaccines to healthy Americans under age 65.